We are live on
!
Find out more
CIP
Capital Insight Partners Portfolio holdings
AUM
$473M
1-Year Est. Return
14.93%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+14.93%
3 Year Est. Return
+51.75%
5 Year Est. Return
+52.67%
10 Year Est. Return
+181.46%
AUM
$114M
AUM Growth
-$7.96M
(-6.5%)
Cap. Flow
-$15.2M
Cap. Flow
% of AUM
-13.41%
Top 10 Holdings %
Top 10 Hldgs %
28.55%
Holding
86
New
10
Increased
1
Reduced
58
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$1.6M |
| 2 |
Moody's
MCO
|
+$1.49M |
| 3 |
RP
RealPage, Inc.
RP
|
+$1.07M |
| 4 |
Watsco Inc
WSO
|
+$1.04M |
| 5 |
SAP
SAP
|
+$836K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$2.45M |
| 2 |
Pfizer
PFE
|
+$2.07M |
| 3 |
Bank of America
BAC
|
+$1.35M |
| 4 |
GSK
GSK
|
+$1.3M |
| 5 |
Snap-on
SNA
|
+$1.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.13% |
| 2 | Industrials | 14.04% |
| 3 | Technology | 13.18% |
| 4 | Healthcare | 11.04% |
| 5 | Communication Services | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$498B
| $4.28M | 3.77% |
19,235
-3,299
| -15% | -$688K |
|
2
Microsoft
MSFT
$2.9T
| $3.15M | 2.77% |
27,564
-3,833
| -12% | -$416K |
|
3
Apple
AAPL
$4.97T
| $3.15M | 2.77% |
55,824
-13,144
| -19% | -$684K |
|
4
Honeywell
HON
$76.4B
| $3.11M | 2.74% |
20,689
-2,840
| -12% | -$403K |
|
5
Alphabet (Google) Class A
GOOGL
$4.12T
| $3.07M | 2.7% |
50,880
-7,500
| -13% | -$454K |
|
|
6
Bank of America
BAC
$429B
| $2.97M | 2.62% |
100,925
-44,440
| -31% | -$1.35M |
|
7
FedEx
FDX
$73B
| $2.94M | 2.58% |
12,190
-1,961
| -14% | -$475K |
|
8
Booking.com
BKNG
$156B
| $2.69M | 2.37% |
33,950
-4,425
| -12% | -$348K |
|
9
Johnson & Johnson
JNJ
$640B
| $2.63M | 2.32% |
19,062
-2,792
| -13% | -$371K |
|
|
STI
10
DELISTED
SunTrust Banks, Inc.
STI
| $2.6M | 2.29% |
38,964
-5,624
| -13% | -$401K |
|
11
ExxonMobil
XOM
$650B
| $2.58M | 2.27% |
30,379
-3,637
| -11% | -$297K |
|
12
Oracle
ORCL
$339B
| $2.56M | 2.26% |
49,727
-7,583
| -13% | -$368K |
|
|
WP
13
DELISTED
Worldpay, Inc.
WP
| $2.5M | 2.2% |
24,654
-3,135
| -11% | -$286K |
|
14
Old Dominion Freight Line
ODFL
$46.3B
| $2.36M | 2.07% |
43,833
-5,760
| -12% | -$292K |
|
15
Trex
TREX
$4.4B
| $2.13M | 1.87% |
55,254
-8,894
| -14% | -$342K |
|
16
Prudential Financial
PRU
$42.6B
| $2.13M | 1.87% |
20,971
-3,221
| -13% | -$318K |
|
|
17
Pfizer
PFE
$143B
| $2.09M | 1.84% |
50,090
-53,642
| -52% | -$2.07M |
|
18
Medtronic
MDT
$112B
| $2.04M | 1.8% |
20,759
-3,143
| -13% | -$291K |
|
19
Factset
FDS
$10B
| $2.02M | 1.78% |
9,047
-1,061
| -10% | -$230K |
|
20
Lumen
LUMN
$6.43B
| $2.01M | 1.77% |
94,954
-13,189
| -12% | -$276K |
|
21
Meta Platforms (Facebook)
META
$1.49T
| $1.99M | 1.75% |
12,127
-1,552
| -11% | -$281K |
|
22
Chemed
CHE
$7.16B
| $1.91M | 1.68% |
5,964
-783
| -12% | -$250K |
|
|
23
Edwards Lifesciences
EW
$49.4B
| $1.9M | 1.67% |
+32,727
| New | +$1.6M |
|
24
3M
MMM
$91.8B
| $1.85M | 1.63% |
10,520
-66
| -0.6% | -$11.4K |
|
25
SLB Ltd
SLB
$72.7B
| $1.66M | 1.46% |
27,284
-3,708
| -12% | -$239K |
|
Similar funds
VW
CAM
VFPW
HFA
GFA
MG
STS
KK
Capital Insight Partners's Q3 2018 Portfolio in Review
As of Q3 2018, Capital Insight Partners held 86 positions worth $114M, down 6.5% from $122M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Insight Partners withdrew a net $15.2M in Q3 2018, closing 9 positions and reducing 58 holdings. Its most notable exit was GSK, an estimated $1.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.
Against the trend, Capital Insight Partners opened a new position in Edwards Lifesciences worth $1.9M.
- Capital Insight Partners's largest Q3 2018 buy was Edwards Lifesciences: 32,727 shares worth $1.9M.
- Capital Insight Partners's biggest Q3 2018 reduction was Wells Fargo, cutting an estimated $2.45M.
- Capital Insight Partners fully exited GSK in Q3 2018, selling an estimated $1.3M.
- Capital Insight Partners's ten largest holdings make up 29% of its $114M portfolio in Q3 2018.
- Capital Insight Partners opened 10 new positions and closed 9 in Q3 2018.
- Capital Insight Partners's portfolio value fell 6.5% quarter-over-quarter to $114M.
Based on Capital Insight Partners's 13F filing for Q3 2018, filed 4 Oct 2018.